Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Avalo Therapeutics, Inc.

AVTX · Nasdaq · CIK 0001534120 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

65 Form 4 transaction lines observed in the same window
34 sales · 31 option, withholding, award, gift or other lines

Last qualifying purchase2024-11-13 · Almenoff June Sherie · $6.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Doyle MittieChief Medical Officer
○▼○○▼○○▼○▼○▼○▼○▼○▼
Sullivan Christopher RyanChief Financial Officer
○▼○▼○○○▼○▼○▼○▼
VARKI PAULChief Legal Officer
○▼○○
Riley JenniferChief Strategy Officer
○○▼
NEIL GARRY ARTHURChief Executive Officer
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2024-11-13 · Almenoff June Sherie.

Recent Form 4 activity

0Purchases
43Sales
49Other Form 4 lines
43SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING34 sale line(s) · context only
OTHER31 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
-17.9%
3M
-28.1%
6M
-0.7%
12M
-11.6%

Volatility & liquidity

Volatility
85.8%
Beta
—
Avg daily value
USD 12.2M

Valuation

Market cap
USD 710.1M
P/E
—

Fundamentals

Profit margin
—
ROE
-94.2%
Industry
Biotechnology

Market data

Price data up to: 2026-10-12 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-08-03 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
11,405,304
Previous report
12,925,869
Avg daily volume
1,296,416
Days to cover
8.8

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2024-11-13Almenoff June SheriePurchase (P)Common Stock500USD 13.00USD 6,500SEC filing ↗
2024-11-12Almenoff June SheriePurchase (P)Common Stock500USD 12.50USD 6,250SEC filing ↗
2023-06-26Caissa Capital Management ltd.Purchase (P)Common Stock1,608,000USD 0.64USD 1,025,474SEC filing ↗
2023-06-20Caissa Capital Management ltd.Purchase (P)Common Stock2,000USD 4.14USD 8,280SEC filing ↗
2023-06-16Caissa Capital Management ltd.Purchase (P)Common Stock3,000USD 3.90USD 11,700SEC filing ↗
2023-06-15Caissa Capital Management ltd.Purchase (P)Common Stock3,160USD 3.68USD 11,629SEC filing ↗
2023-06-14Caissa Capital Management ltd.Purchase (P)Common Stock6,000USD 3.48USD 20,880SEC filing ↗
2023-06-13Caissa Capital Management ltd.Purchase (P)Common Stock8,750USD 3.82USD 33,425SEC filing ↗
2023-06-12Caissa Capital Management ltd.Purchase (P)Common Stock2,149USD 4.34USD 9,327SEC filing ↗
2023-06-09Sullivan Christopher RyanPurchase (P)Common Stock511USD 3.42USD 1,748SEC filing ↗
2023-06-09NEIL GARRY ARTHURPurchase (P)Common Stock4,000USD 3.42USD 13,680SEC filing ↗
2023-06-09Caissa Capital Management ltd.Purchase (P)Common Stock5,044USD 4.14USD 20,882SEC filing ↗
2023-06-08Caissa Capital Management ltd.Purchase (P)Common Stock6,398USD 3.93USD 25,144SEC filing ↗
2023-06-07Caissa Capital Management ltd.Purchase (P)Common Stock2,984USD 3.49USD 10,414SEC filing ↗
2023-05-31Caissa Capital Management ltd.Purchase (P)Common Stock844USD 2.87USD 2,422SEC filing ↗

Form 4 evidence

92 transaction lines in the latest 365-day window; 236 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-16Sullivan Christopher RyanSale (S)Common Stock12,394USD 16.33USD 202,394SEC filing ↗
2026-09-16Sullivan Christopher RyanOption exercise / conversion (M)Common Stock12,394USD 9.88USD 122,453SEC filing ↗
2026-09-10Sullivan Christopher RyanSale (S)Common Stock10,185USD 17.62USD 179,460SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-16Sullivan Christopher RyanSale (S)Common Stock12,394USD 16.33USD 202,394SEC filing ↗
2026-09-16Sullivan Christopher RyanOption exercise / conversion (M)Common Stock12,394USD 9.88USD 122,453SEC filing ↗
2026-09-10Sullivan Christopher RyanSale (S)Common Stock10,185USD 17.62USD 179,460SEC filing ↗
2026-09-10Sullivan Christopher RyanOption exercise / conversion (M)Common Stock10,185USD 8.04USD 81,887SEC filing ↗
2026-08-28Doyle MittieSale (S)Common Stock679USD 20.00USD 13,580SEC filing ↗
2026-08-28Doyle MittieOption exercise / conversion (M)Common Stock679USD 8.04USD 5,459SEC filing ↗
2026-08-18Sullivan Christopher RyanSale (S)Common Stock31,031USD 20.05USD 622,172SEC filing ↗
2026-08-18Sullivan Christopher RyanOption exercise / conversion (M)Common Stock31,031USD 9.88USD 306,586SEC filing ↗
2026-08-17Sullivan Christopher RyanSale (S)Common Stock41,694USD 19.86USD 827,963SEC filing ↗
2026-08-17Sullivan Christopher RyanOption exercise / conversion (M)Common Stock40,821USD 9.88USD 403,311SEC filing ↗
2026-08-17Doyle MittieSale (S)Common Stock1,000USD 20.00USD 20,000SEC filing ↗
2026-08-17Doyle MittieOption exercise / conversion (M)Common Stock1,000USD 12.65USD 12,650SEC filing ↗
2026-08-11Riley JenniferSale (S)Common Stock2,655USD 19.59USD 52,011SEC filing ↗
2026-08-10Doyle MittieSale (S)Common Stock679USD 20.00USD 13,580SEC filing ↗
2026-08-10Doyle MittieOption exercise / conversion (M)Common Stock679USD 8.04USD 5,459SEC filing ↗
2026-07-27Doyle MittieSale (S)Common Stock1,000USD 20.00USD 20,000SEC filing ↗
2026-07-27Doyle MittieOption exercise / conversion (M)Common Stock1,000USD 12.65USD 12,650SEC filing ↗
2026-06-30Doyle MittieSale (S)Common Stock4,654USD 20.00USD 93,080SEC filing ↗
2026-06-30Doyle MittieOption exercise / conversion (M)Common Stock4,654USD 10.89USD 50,672SEC filing ↗
2026-06-23Doyle MittieSale (S)Common Stock1,450USD 18.00USD 26,100SEC filing ↗
2026-06-23Doyle MittieOption exercise / conversion (M)Common Stock1,450USD 8.04USD 11,658SEC filing ↗
2026-06-10VARKI PAULTax withholding (F)Common Stock1,081USD 13.10USD 14,161SEC filing ↗
2026-06-10Sullivan Christopher RyanTax withholding (F)Common Stock138USD 13.10USD 1,808SEC filing ↗
2026-06-10Riley JenniferTax withholding (F)Common Stock588USD 13.10USD 7,703SEC filing ↗
2026-06-10Doyle MittieTax withholding (F)Common Stock1,084USD 13.10USD 14,200SEC filing ↗
2026-05-28Doyle MittieSale (S)Common Stock679USD 16.00USD 10,864SEC filing ↗
2026-05-28Doyle MittieOption exercise / conversion (M)Common Stock679USD 8.04USD 5,459SEC filing ↗
2026-05-21VARKI PAULAward / grant (A)Common Stock24,300USD 0.00USD 0SEC filing ↗
2026-05-21Sullivan Christopher RyanAward / grant (A)Common Stock39,900USD 0.00USD 0SEC filing ↗
2026-05-21Riley JenniferAward / grant (A)Common Stock34,200USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerAVTX
CIK0001534120
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history236 transaction lines from 2020-01-22 to 2026-09-16
121 P purchase lines · 45 S sale lines · 70 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.